These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis. Li Y, Yang L, Sha K, Liu T, Zhang L. Int J Infect Dis; 2016 Dec; 53():52-58. PubMed ID: 27810523 [Abstract] [Full Text] [Related]
5. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans. Jung YK, Kim JH, Ahn SM, Yang JW, Park SJ, Kim JW, Yeon JE, Kwon OS, Kim YS, Choi DJ, Kim JH, Byun KS. J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843 [Abstract] [Full Text] [Related]
7. Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection. Thong VD, Wasitthankasem R, Tangkijvanich P, Vongpunsawad S, Poovorawan Y. PLoS One; 2015 Aug; 10(5):e0125400. PubMed ID: 25938236 [Abstract] [Full Text] [Related]
10. Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population. Huang P, Yao Y, Yue M, Tian T, Chen H, Chen M, Wang J, Zhang Y, Yu R. Sci Rep; 2017 Feb 10; 7():42408. PubMed ID: 28186161 [Abstract] [Full Text] [Related]
11. IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians. Real LM, Neukam K, Herrero R, Guardiola JM, Reiberger T, Rivero-Juarez A, Salazar J, Mandorfer M, Merino D, Soriano V, Rivero A, Macías J, Pineda JA, Caruz A. PLoS One; 2014 Feb 10; 9(4):e95515. PubMed ID: 24748394 [Abstract] [Full Text] [Related]
13. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy. Aziz H, Raza A, Ali K, Khattak JZ, Irfan J, Gill ML. Int J Infect Dis; 2015 Jan 10; 30():91-7. PubMed ID: 25462177 [Abstract] [Full Text] [Related]
16. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C. Ishiguro H, Abe H, Seki N, Sugita T, Aida Y, Itagaki M, Sutoh S, Shimada N, Furihata T, Tsubota A, Aizawa Y. World J Gastroenterol; 2015 Apr 07; 21(13):3904-11. PubMed ID: 25852275 [Abstract] [Full Text] [Related]
17. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C. Susser S, Herrmann E, Lange C, Hamdi N, Müller T, Berg T, Perner D, Zeuzem S, Sarrazin C. PLoS One; 2014 Apr 07; 9(11):e112592. PubMed ID: 25393304 [Abstract] [Full Text] [Related]
18. Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms. Ling Q, Chen J, Zhou H, Zhong J, Chen Y, Ye Q, Zhuo Y, Min N, Shang B. Arch Virol; 2015 Apr 07; 160(4):1105-12. PubMed ID: 25687192 [Abstract] [Full Text] [Related]
19. IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection. Lin CY, Chen JY, Lin TN, Jeng WJ, Huang CH, Huang CW, Chang SW, Sheen IS. PLoS One; 2011 Mar 30; 6(3):e18322. PubMed ID: 21479134 [Abstract] [Full Text] [Related]